Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. September 2023 07:00 ET | Quelle: CytoSorbents

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

CytoSorbents summarizes real-world data from STAR Registry analysis being presented next week at European Association of Cardio-Thoracic Surgery Congress
07. März 2023 07:00 ET | Quelle: CytoSorbents

New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time

PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
04. Mai 2021 04:28 ET | Quelle: Research and Markets

China Apixaban Market Report 2021: Analysis of Major Manufacturers 2016-2020, Prices 2020-2021 & Prospects 2021-2025

Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Apixaban Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The sales revenue of Apixaban...
28. März 2019 08:05 ET | Quelle: Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Provides Management Team Updates

Mark Tepper, Ph.D., transitions to role of external Senior Scientific Advisor Robert Discordia, Ph.D., role expanded to lead Chemistry, Manufacturing and Controls operationsSergei Atamas, M.D.,...